Viracta Therapeutics, Inc. - VIRX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2020 · Q3 2020
Value (USD)
Total reported value ($000)
$1.452M
QoQ value delta ($000)
-$6K (-0.41%)
Implied price effect (QoQ)
+59.35%
Shares
Total shares
729,930
QoQ shares delta
-437,996 (-37.5%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (VIRX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2020)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 671 337,529 0.0%
GEODE CAPITAL MANAGEMENT, LLC 166 83,552 0.0%
CITADEL ADVISORS LLC 117 58,801 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 110 55,200 0.0%
BAKER BROS. ADVISORS LP 106 53,066 0.0%
WELLS FARGO & COMPANY/MN 78 39,358 0.0%
GOLDMAN SACHS GROUP INC 62 31,389 0.0%
NORTHERN TRUST CORP 57 28,815 0.0%
BOOTHBAY FUND MANAGEMENT, LLC 43 21,400 0.0%
GROUP ONE TRADING, L.P. 18 8,878 0.0%
UBS Group AG 9 4,207 0.0%
MORGAN STANLEY 7 3,618 0.0%
BANK OF AMERICA CORP /DE/ 4 2,003 0.0%
Tower Research Capital LLC (TRC) 4 1,845 0.0%
ROYAL BANK OF CANADA 0 159 0.0%
Parallel Advisors, LLC 0 32 0.0%
Valeo Financial Advisors, LLC 0 15 0.0%
Steward Partners Investment Advisory, LLC 0 63 0.0%